HIV/AIDS
Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
Published in Health Business Week, February 15th, 2008
David Wetherell, Lentigen's chairman, commented, "The board of Lentigen is delighted that Tim has agreed to lead Lentigen, as we are about to enter clinical trials for our first therapies later this year for Glioblastoma and GVHD. His particularly strong background and global leadership in healthcare products will serve Lentigen well as we advance with our broad set of product lines, therapeutics and collaborations."
Having most recently served as president of Bristol-Myers Squibb (BMS) Medical Imaging, Mr. Ravenscroft has more than 29 years' international...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2008-02-15)
More Articles from Health Business Week
- "Interest in fresh breath highest among 18-24 year olds" - Oral
Kimberly-Clark Launches DentaBurst(TM) Freshening Teeth Cleaners - 50 Million Pound Challenge
50 Million Pound Challenge Teams Up With Churches to Spread the 'Gospel of Healthy Living' - Abbey Spanier Rodd & Abrams, Llp
Abbey Spanier Rodd & Abrams, LLP Files Class Action Lawsuit on Behalf of Purchasers of American Dental Partners, Inc. Securities - Abbott
Abbott to Present at Merrill Lynch Healthcare Conference - Access Pharmaceuticals, Inc.
Access Pharmaceuticals Announces $2.7 Million New Equity - Acesis Inc.
Status: - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
